Senator Claire McCaskill's Public Statements

Office: U.S. Senate (MO) - Sr, Democratic
Issue Category
Keyword Search
6/09/16 Cable, Satellite Customer Service to be Focus of McCaskill-Portman Hearing 6/07/16 McCaskill Seeks Drug Pricing Information on Opioid Overdose Reversal Drugs 6/06/16 Chairman Collins, Ranking Member McCaskill Seek Information from Companies on Efforts to Preserve Accessibility of Opioid Overdose Reversal Drug 5/18/16 McCaskill Takes Wind out of Flimsy Arguments for Loosening Robocall Restrictions 5/16/16 Federal News Radio (DMV) - Vendor Hired to Improve Security of Opm's Network Goes Out of Business 5/13/16 Letter to The Honorable Beth Cobert, Acting Director, U.S. Office of Personnel Management 5/13/16 St. Louis Post-Dispatch - Congress Moves on Several St. Louis-Related Fronts 5/13/16 "What on Earth Did You Think Would Happen?' -- Mccaskill, on Learning Disgraced Contractor for It Overhaul Has Now Defaulted on Contract 5/12/16 Letter to Credit Reporting Agencies - Fighting to Protect Consumers 5/12/16 With Credit Reporting Errors Harming Missourians, McCaskill Keeps up Fight to Protect Consumers 5/11/16 Federal News Radio - Senators Want New Commerce IG to Have the Authority to Do the Job Right 5/11/16 Missouri Manufacturers Will See Simpler Trade Processes as McCaskill Plan Heads to President's Desk 4/28/16 U.S. House Approves McCaskill Plan to Simplify Trade Processes for Missouri Manufacturers 4/28/16 McCaskill: This Business Model Uses Patients as Hostages 4/27/16 Business Insider - Bill Ackman and Valeant Execs Just Got Through One of the Most Brutal Senate Hearings We've Ever Seen 4/27/16 AP - Senate Lawmakers Accused Embattled Drugmaker Valeant Pharmaceuticals of Hiking Prices to Reward Wall Street Investors at the Expense of Patients 4/27/16 Hearing of the Senate Aging Committee - Sen. McCaskill's Opening Statement on "Valeant Pharmaceuticals' Business Model: the Repercussions for Patients and the Health Care System" 4/27/16 The New York Times - Valeant Chief, at Senate Hearing, Concedes Mistakes on Steep Drug Prices 4/27/16 Bloomberg - Ackman, Valeant Offer Apologies, Concessions at Drug Hearing 4/27/16 Washington Examiner - Senators Not Buying Drugmaker's Contrition 4/21/16 Postal Service "Last Mile' Pricing is Topic as McCaskill Aims to Protect Rural Delivery for Missourians 4/14/16 McCaskill Shines Spotlight on State of Nation's Biodefense 4/13/16 Valeant CEO Reverses Course: Senate Special Committee on Aging to Depose Michael Pearson 4/13/16 Congressional Leadership "Finally' Embraces McCaskill-Portman Reforms for American Manufacturer Tariff Relief 4/11/16 Senate Special Committee on Aging Calls Business Meeting to Initiate Contempt Proceedings Against Valeant CEO Michael Pearson 4/07/16 Letter to The Honorable Robert M. Califf, M.D., Commissioner, U.S. Food and Drug Administration - After Study Exposes Banned Rx Drugs in Dietary Supplements, McCaskill Asks FDA What They Knew and When 4/06/16 McCaskill Presses Top Transportation Security Official on Safety, Security of Foreign Repair Stations for U.S. Aircraft 4/04/16 Popular weight loss supplements contain controversial stimulant, FDA warns 4/04/16 Natural Products Insider - FDA Identifies Unlawful Ingredient, "Methylsynephrine,' in Sports Supplements 3/31/16 Letter to The Honorable Loretta Lynch, Attorney General, United States Department of Justice - Requesting Records of Enforcement Actions Taken by Department of Justice on Dietary Supplements 3/30/16 Letter to The Honorable Penny Pritzker, Secretary, United States Department of Commerce - Fighting to Level the Playing Field for Missouri Manufacturers 3/28/16 Letter to Administrator McCarthy - Urging EPA to Release Strong Renewable Fuel Standard to Support Homegrown Ethanol Production 12/17/15 Collins, McCaskill Statement on Arrest of Martin Shkreli on Securities Fraud Charges 12/09/15 Hearing of the Senate Aging Committee - Opening Statement of Sen. McCaskill, Hearing on Sudden Price Spikes in Off-Patent Drugs: Perspectives from the Front Lines 11/04/15 Collins, McCaskill Open Senate Investigation into Rx Drug Pricing, Announce Intention to Hold Hearings 9/30/15 Bill to Boost Small Businesses with Fix in the Affordable Care Act Earns McCaskill's Support 9/28/15 Letter to Mr. J. Michael Pearson, Chairman of the Board and Chief Executive Officer, Valeant Pharmaceuticals International, Inc. - Provide Information on Drug Price Hikes to Permanent Subcommitee on Investigations 9/16/15 Reauthorization of the Export-Import Bank 9/14/15 KMZU Radio - U.S. Senator Claire McCaskill Addresses Agriculture Tour, Resort Fees 9/02/15 KFEQ Radio 9/02/15 The Kanasas City Star - Sen. Claire McCaskill Expresses Food Desert Frustration and Seeks Action 9/02/15 emissourian - Senator Stops At Area Farm -- McCaskill's Ag Tour Visits Todd Geisert Farms 9/02/15 As McCaskill Scrutinizes Deceptive Hotel Fees, Advisory Panel Recommends a Crackdown 7/30/15 Hearing of the Permanent Subcommittee on Investigations of the Senate Committee on Homeland Security and Governmental Affairs - Opening Statement of Senator McCaskill, Hearing on the Impact of the U.S. Tax Code on the Market for Corporate Control and Jobs 7/22/15 St. Louis Public Radio - McCaskill Wants to Hear About Hidden Hotel Fees 7/14/15 Feast Magazine - Claire McCaskill Throws Support behind the Small BREW Act to Encourage Missouri's Microbreweries 6/17/15 McCaskill Opens Inquiry into "Brain Armor' and Other Dietary Supplements Targeting Seniors 6/15/15 Letter to Larry Page, CEO of Google Inc - Google Shopping 6/15/15 Letter to Stephen Ostroff, Commissioner of the Food and Drug Administration - Dietary Supplements Targeting Seniors 6/10/15 KMOX Radio - Sen. Claire McCaskill Supports the Small Brew Act

Help us stay free for all your Fellow Americans

Just $5 from everyone reading this would do it.